Related references
Note: Only part of the references are listed.Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers
Stephanie Korn et al.
RESPIRATION (2020)
ARE WE MEETING THE PROMISE OF ENDOTYPES AND PRECISION MEDICINE IN ASTHMA?
Anuradha Ray et al.
PHYSIOLOGICAL REVIEWS (2020)
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Manali Mukherjee et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Diagnosis and Management of T2-High Asthma
Andrea M. Coverstone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
The interleukin-13 paradox in asthma: effective biology, ineffective biologicals
Parameswaran Nair et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis
Rahul Shrimanker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Association between exhaled nitric oxide and nasal polyposis in severe asthma
Mauro Maniscalco et al.
RESPIRATORY MEDICINE (2019)
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Manali Mukherjee et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2019)
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
David B. Price et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2019)
Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma
Jonas S. Erjefalt
CURRENT OPINION IN PULMONARY MEDICINE (2019)
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab
Manali Mukherjee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007-12
I. Mogensen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Sputum autoantibodies in patients with severe eosinophilic asthma
Manali Mukherjee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels
John Haughney et al.
RESPIRATORY MEDICINE (2018)
Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol
Anna von Bulow et al.
RESPIRATORY MEDICINE (2018)
Severe eosinophilic asthma: a roadmap to consensus
Roland Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Diane Lefaudeux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma
Elizabeth A. Kelly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma
R. Sehmi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
Steven G. Smith et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity
Andrei Malinovschi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Guus A. Westerhof et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma
David F. Choy et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis
Daniel A. Korevaar et al.
LANCET RESPIRATORY MEDICINE (2015)
External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
A. H. Wagener et al.
THORAX (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Florence Nicole Schleich et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes
Katherine J. Baines et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Current evidence and future research needs for FeNO measurement in respiratory diseases
Leif Bjermer et al.
RESPIRATORY MEDICINE (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma
Gilles Garcia et al.
CHEST (2013)
Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects
Andrei Malinovschi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation
Hiroki Kabata et al.
NATURE COMMUNICATIONS (2013)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary Disease
M. Bafadhel et al.
RESPIRATION (2012)
Interrater reliability: the kappa statistic
Mary L. McHugh
BIOCHEMIA MEDICA (2012)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Wendy C. Moore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Assessment and Reproducibility of Non-Eosinophilic Asthma Using Induced Sputum
Jodie L. Simpson et al.
RESPIRATION (2010)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet et al.
ALLERGY (2008)
Cluster analysis and clinical asthma phenotypes
Pranab Haldar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells
K. Chibana et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
American Thoracic Society et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath
C Lane et al.
THORAX (2004)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Share Paper
